Marker Therapeutics, Inc.MRKRNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-229.62%
↑ 98% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-9879.48%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -229.62% | -36.1% |
| 2024 | -168.69% | +52.6% |
| 2023 | -356.14% | +26.4% |
| 2022 | -483.90% | +84.5% |
| 2021 | -3117.98% | +47.3% |
| 2020 | -5919.21% | +43.7% |
| 2019 | -10517.97% | +85.4% |
| 2018 | -71830.25% | -1064.0% |
| 2017 | -6171.07% | - |
| 2016 | 0.00% | - |